In the present review, we will discuss the MDMX protein structure and the role of MDMX in the p53-MDM2/MDMX loop but mainly focus on the clinical relevance of MDMX in cancer, current MDMX-targeting strategies and related MDMX inhibitors, and other potential strategies for developing new MDMX inhibitors. This evidence concerns the gene TP53 and cancer.